P.ZhongW
They recommend ongoing surveillance as with any medication, but they havent found evidence of increased risk
A little more than a year later, she no longer has a diabetes diagnosis
This cooling effect minimizes the risk of burns and other side effects
Zhou added, Small molecule GLP-1RAs, such as ECC5004, could potentially offer more dosing convenience and ease of use compared to existing GLP-1RA therapies. Under the agreement, AstraZeneca is granted exclusive global rights for the development and commercialization of ECC5004 for any indication in all territories except China, where Eccogene has the right to co-develop and co-commercialize in China alongside AstraZeneca

Consult your GP if you experience: Persistent low libido despite restoring adequate caloric intake for 36 months Complete loss of sexual desire that causes significant personal distress or relationship difficulties Amenorrhoea (absent periods) for three consecutive cycles or longer Erectile dysfunction in men, particularly if sudden onset or progressive (erectile dysfunction can be an early marker of cardiovascular disease risk and may warrant cardiovascular risk assessment) [18] [19] Additional symptoms such as unexplained fatigue, mood changes, hair loss, cold intolerance, or unintentional weight changes Signs of eating disorders , including preoccupation with food, body dysmorphia, or purging behaviours Your GP can conduct a thorough assessment including medical history, examination, and appropriate investigations